News & Events

  • NewsTop 10 promosing technologies leading the medical device industry: Patient-specific dental model, Brain PET, Peripheral microvascular disgnostic d...

    Top 10 promosing technologies leading the medical device industry: Patient-specific dental model, Brain PET, Peripheral microvascular disgnostic device... Leading South Korea to a stronghold of medical devicesThe government has announced the top 10 key technologies aimed at propelling South Korea to become the 5th largest exporter of medical devices, with an estimated medical device export value of approximately 21 trillion won by 2027. The selection includes groundbreaking medical devices that are expected to be developed for the first time globally, as well as initiatives focused on domesticating imported medical devices, addressing public health and social issues. The government plans to continuously foster future growth opportunities by unveiling 10 representative projects each year.On the 23rd, the Medical Device Research and Development Project Group held the "2023 Performance Report Conference" at The Westin Chosun Seoul hotel, where they announced the top 10 representative projects. This performance report conference, which was jointly sponsored by the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health and Welfare, and the Ministry of Food and Drug Safety, marked its first occurrence since the establishment of the task force.Kim Beob-min, the head of the task force, explained, "Since its establishment, we have built a support system as a platform to enhance the success rate of medical device research and development (R&D) and generate excellent results by providing support for various research projects. We will actively communicate with researchers and promote the commercialization of medical devices." He added, "The leading projects selected each year may involve technologies that have been previously selected, as well as new technologies."The selected representative projects are expected to play a pivotal role in achieving the government's goal of becoming the 5th largest exporter of medical devices, which was set by Yoon Seok Yeol government. In February of this year, the government announced plans to expand the medical device export value from approximately 8.6 billion dollars in 2021 to 16 billion dollars by 2027, positioning South Korea as a leading exporter in the field.The 10 projects announced include promising fields such as medical imaging diagnosis, in vitro diagnostics, dental technology, and digital health. Among them, three projects are anticipated to win the world's first title. Director Kim stated, "We selected these projects based on evaluations considering the appropriateness of research and development execution, technological and medical aspects, as well as the socio-economic ripple effects, out of a total of 869 achievements submitted by 90 organizations."The followings are the top 10 medical device projects, the institutions involved, and their development status that have been underway since 2020. [omitted]Development of Brain PET System and Integrated Molecular Imaging Platform to Overcome Neurodegenerative Brain DiseasesBrightonix Imaging aims to domestically produce medical device by developing brain PET system targeting neurodegenerative diseases such as dementia and Parkinson's disease. Currently, for the diagnosis of neurodegenerative diseases in the elderly, the combination of computed tomograhy (CT) or magnetic resonance imaging (MRI) is essential. However, this technology visualizes functional changes in the brain using PET only for disease diagnosis. Brightonix Imaging received the Korean Innovation Sartup Award by the Minister of Science and ICT. The project runs from September 1, 2020, to December 31, 2025, with government funding of 11.66 billion won. [Omitted] <Copyright holder ⓒ Prohibition of unauthorized reproduction and redistribution of Chosun Biz Newspapers>Source: 환자 맞춤형 치과모델·뇌전용PET·말초 미세혈관 진단기기...의료기기 강국 이끌 10대 유망 기술 - 조선비즈 (chosun.com)

  • NewsBrightonix Imaging selected for Post-TIPS, propelling its leap towards becoming a global unicorn company

    Brightonix Imaging selected for Post-TIPS, propelling its leap towards becoming a global unicorn companyBrightonix Imaging (led by Jae Sung Lee, CEO), a medical imaging solution company, announced that it has been selected for the "Post-TIPS" project organized by the Ministry of SMEs and Startups. Post-TIPS is a program that selects and supports promising startup companies verified through TIPS, with a focus on facilitating their substantial scale-up and fostering global unicorn companies.Through this program, Brightonix Imaging will receive funding of 500 million won for 18 months to enhance its business operations, and will have support for open innovation, scale-up, and global expansion through the Korea Institute of Science Technology (KIST), the organizing institute for Post-TIPS. Since its selection in the TIPS program in 2018, Brightonix Imaging has advanced its preclinical PET system technology and has been developing a high-resolution PET system for brain through the Korea Medical Device Development Fund in 2020. Furthermore, their AI-based brain PET image analysis solution, BTXBrain, has received approval from the Ministry of Food and Drug Safety as a medical device in December 2022 and is being rapidly deployed in domestic medical institutions.Brightonix Imaging, which leads technological innovation in the field of advanced medical imaging has also received the 2022 Korea Innovative Startup Award (Minister of Science and ICT Award), and plans to accelerate global expansion through product certifications and marketing. With the selection for the Post-TIPS program, Brightonix Imaging has gained an opportunity to leap forward as a growing company in the global market.  <Copyright holder ⓒ Prohibition of unauthorized reproduction and redistribution of Yakpum Newspapers>Source: 브라이토닉스이미징, 포스트팁스 선정… 글로벌 유니콘기업으로 도약한다-약품신문 - http://www.yakpum.co.kr/5491

  • NewsBrightonix Imaging received the Innovation Start-up Korea Award granted by the Minister of Science and ICT

    Six start-ups win Innovation Start-up Korea AwardsThe JoongAng Ilbo, KAIST and Seoul National University (SNU) hosted the annual International Symposium on 'Korea, the Country of Innovation and Start-ups' on Tuesday at SNU's campus in southern Seoul. From left: KAIST President Lee Kwang-hyung, Science Minister Lee Jong-ho, JoongAng Holdings Chairman Hong Seok-hyun and SNU President Oh Se-Jung. [KIM SANG-SEON] The JoongAng Ilbo, KAIST and Seoul National University (SNU) jointly launched an annual conference to instill entrepreneurship into Korea's business scene and recognize young tech firms with high growth potential.   In the first International Symposium on 'Korea, the Country of Innovation and Start-ups' Tuesday, six Korean start-ups won awards for their innovative approach towards business. The three sponsors plan to host the symposium every year at the end of the year, based on an agreement signed in October.The Tuesday event brought together entrepreneurship specialists, including Ami Appelbaum, chairman of the Israel Innovation Authority, and Scott Stern, professor at the MIT Sloan School of Management. Also present were JoongAng Holdings Chairman Hong Seok-hyun, Science Minister Lee Jong-ho, KAIST President Lee Kwang-hyung and SNU President Oh Se-Jung.   Bio start-ups Tomocube and Brightonix Imaging won the Innovation Start-up Korea Award granted by the science minister.   Tomocube develops high-performance laboratory microscopes using a technique called holotomography, while Brightonix Imaging has an expertise on medical imaging analysis.   Quantum Cat, a Daejeon-based firm specializing in the use of gold as a catalyst, won the award given by the SNU president.   FriendliAI, a start-up offering services that facilitate artificial intelligence analytics, grabbed the award granted by the president of KAIST. The Innovation Start-up Korea Award given by the JoongAng Holdings chairman went to Recense Medical, which makes medical devices designed for cooling cells. Pinotbio, a provider of anticancer drug technology, took home the award given by the head of National Research Council on Science & Technology.   In a welcome speech, Chairman Hong shared a story of former Israel President Shimon Peres, who is credited with propelling Israel into a hub for innovation and high-tech start-ups.   “Nestled in the southern part of Tel Aviv, a building with floor-to-ceiling windows – Peres Center for Peace and Innovation – stood near the Mediterranean Sea. The center features how Israel transformed into the home to innovative start-ups,” Hong said.   “As a country with 9 million people, Israel is battered by conflicts with neighboring Islamic countries, and poor in resources, with half of the land in the state of desert,” Hong said, “The only resource was the people, which became the basis of the miracle,” he said.   The chairman went on to stress the importance of efficiently turning breakthrough ideas into viable business opportunities.   “The problem is the so-called R&D paradox,” Hong said, “Many stellar research feats failed to grow into new growth engines."   To resolve the problem, Korea needs to embrace the spirit of the first mover, according to the KAIST President Lee.   “Korea should go beyond following other advanced countries,” Lee said, “We need a transformation to become a leading nation through research and development and the building of innovative companies.” Science Minister Lee vowed to provide more support for nurturing high-tech start-ups.   “We will foster a deeper tie between public research institutions and private institutions and amend regulations standing in the way of entrepreneurs’ efforts to run their businesses,” he said.BY PARK EUN-JEE [park.eunjee@joongang.co.kr]Six start-ups win Innovation Start-up Korea Awards (joins.com)

  • NewsJae Sung Lee, CEO of Brightonix Imaging receives Medical Imaging Technical Achievement Award at IEEE/NPSS 2022

    Jae Sung Lee, a professor of nuclear medicine at Seoul National University Hospital and CEO of Brightonix Imaging, won the "Medical Imaging Technical Achievement Award" at the 2022 IEEE NSS/MIC/RTSD on the 5th November 2022.Professor Lee was recognized for his academic achievements in developing the world's first silicon photomultiplier PET, a key technology in the digital positron tomography systems, and solving various challenges in the medical imaging field with artificial intelligence technology.He also won the award for his international leadership, including the MIC chair of the IEEE NSS/MIC/RTSD (2013 and 2021), the chair of the Nuclear Medical and Imaging Sciences Council of the IEEE Nuclear and Plasma Sciences Society (2018~2019), and the editor-in-chief of Biomedical Engineering Letters (2016~present). Meanwhile, Professor Lee was recently elected AdCom member of the IEEE Nuclear and Plasma Sciences Society and was appointed MIC co-chair of the 2025 IEEE NSS/MIC/RTSD in Yokohama, Japan.<저작권자 ⓒ 후생신보 무단전재 및 재배포 금지>  |   이상철 기자 출처 : 서울대병원 이재성 교수, 국제전기전자공학회 의료영상기술공로상 :후생신보 (whosaeng.com)

  • NewsBrightonix Imaging presents the future of imaging for dementia at EANM 2022

    Brightonix Imaging presents the future of imaging for dementia at EANM 2022High resolution, multi-purpose PET system that delivers higher performance while reducing footprint and deployment costsBrightonix Imaging said that the positron tomography (PET) scanner, which is being developed with the support of the Korea Medical Device Development Fund, received a lot of attention and response from participants at the 2022 Annual Congress of the European Association of Nuclear Medicine (EANM 2022) held at the Barcelona International Convention Center from the 15th to the 19th October.Brightonix Imaging, which operated the exhibition booth at EANM 2022, the world's largest nuclear medicine and molecular imaging society (6800 registered people in 2022), introduced Korea's advanced nuclear medicine imaging equipment and software technology.Lecanemab, a new drug candidate for Alzheimer's dementia jointly developed by Biogen and Ezai, recently showed good results of improved cognitive function, in phase 3 of clinical trial. This has drawn attention to the importance of brain PET scans that provide accurate information on the distribution of amyloid and tau protein in patients with Alzheimer's dementia.The company said, "Because PET-CT specialized in cancer diagnosis requires billions of won and a very large footprint, interest in the brain-dedicated PET system is increasing. Our multi-purpose high-resolution PET is designed to take brain scans in a sitting or lying position compared to other products, and we had more than 1,000 visitors at our booth over the three days."Jae Sung Lee, CEO of Brightonix Imaging, said, "The high-resolution multipurpose PET system, which reduces the installation space and cost while providing higher performance, will help conquering Alzheimer's dementia by increasing the accuracy of early diagnosis and treatment effect estimation."Dr. Andrew Lonergan, who oversees the exhibition of the Brightonix Imaging in European conferences, said, "It is very unusual that the global sales and service network base are built just in days by such active partnership proposals from distributors and service providers of medical imaging equipment in Europe and major Asian countries."저작권자© 메디게이트뉴스, 무단 전재 및 재배포 금지   |   임솔 기자 (sim@medigatenews.com)출처: MEDI:GATE NEWS 브라이토닉스이미징, 세계 핵의학 컨퍼런스에서 치매영상 미래 제시 (medigatenews.com)

  • NewsBrightonix Imaging presents AI solutions for brain PET imaging at SNMMI 2022

    Brightonix Imaging presents AI solutions for brain PET imaging at SNMMI 2022Validations of automated quantification analysis software for amyloid PET and DAT PET to aid diagnosis of Alzheimer's disease and Parkinson's diseaseBrightonix Imaging, a medical imaging solution developing company, announced on the 16th June 20022 that it exhibited the latest AI solutions for dementia image analysis and small animal PET system for PET/MRI at the annual meeting of Society of Nuclear Medicine and Molecular Imaging (SNMMI) held at the Vancouver Convention Center in Canada from the 11th to the 14th June 2022.In the SNMMI, researchers at Seoul National University and Brightonix Imaging announced the validation results of amyloid PET and dopamine PET automatic analysis software to support the diagnosis of Alzheimer's dementia and Parkinson's disease. In addition, collaboration possibilities were discussed with radiopharmaceutical companies such as Eli Lilly, Merck, and LMI to develop Tau PET quantitative analysis technologies.Jae Sung Lee, CEO of Brightonix, who is also a professor at the department of nuclear medicine of Seoul National University, was invited as a keynote speaker at the Workshop on Fast Timing in Medical Imaging held in Valencia, Spain, for three days from the 3rd June. He introduced the current status of development of brain-dedicated PET scanner equipped with precision timing measurement technology and AI solutions of Brightonix imaging.Brightonix Imaging is invested by K-Net Investment, an early investor in Krafton, which created the popular shooting game "Battleground". Recently, it received 6 billion won worth of Series A investment from Hana Ventures and TS Investment. Two years after its establishment, it supplied a PET system to NIH in the U.S., and was selected as the principal investigator of a 14 billion won project supported from the Korean Medical Device Development Fund.Brightonix Imaging's AI-based brain image quantitative analysis software was developed with the support from the Seoul Business Agency’s bio-medical technology commercialization support project, and the development of a brain-dedicated PET system is supported by the Korea Medical Device Development Fund.저작권자© 메디게이트뉴스, 무단 전재 및 재배포 금지    |   임솔 기자 (sim@medigatenews.com)출처 : MEDI:GATE NEWS 브라이토닉스이미징, 치매영상 신기술 북미핵의학분자영상학회서 발표 (medigatenews.com)

1 2